US Stock MarketDetailed Quotes

XFOWW X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B

Watchlist
  • 0.012
  • 0.0000.00%
15min DelayClose Aug 13 16:00 ET
0Market Cap0.00P/E (TTM)

X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.40%-34.03M
-41.32%-30.28M
-26.72%-33.6M
-25.17%-96.51M
-45.33%-27.75M
-7.88%-20.83M
-15.97%-21.43M
-31.06%-26.51M
-8.74%-77.1M
-0.21%-19.09M
Net income from continuing operations
-1,492.02%-36.7M
263.04%90.83M
-115.51%-51.77M
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
Operating gains losses
107.41%1.86M
-519.34%-125.22M
352.90%13.76M
-345.54%-7.07M
---6.33M
---25.16M
--29.86M
---5.44M
687.16%2.88M
----
Depreciation and amortization
156.73%267K
53.97%194K
-51.18%62K
-18.32%419K
-50.00%62K
-16.13%104K
-4.55%126K
-4.51%127K
2.81%513K
-6.06%124K
Other non cash items
-41.51%372K
-29.04%435K
-6.44%523K
-6.44%2.28M
11.08%471K
-45.87%636K
55.98%613K
25.90%559K
-2.01%2.44M
-31.06%424K
Change In working capital
-146.86%-1.66M
-32.21%1.05M
239.29%2.09M
-94.00%344K
-197.86%-5.36M
2,823.08%3.54M
123.73%1.55M
305.33%616K
482.91%5.74M
512.90%5.48M
-Change in inventory
---1.61M
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
-905.00%-201K
120.93%336K
-49.04%1.06M
-124.59%-1.37M
-138.15%-1.83M
96.98%-20K
-97.66%-1.61M
27.62%2.08M
65.24%-610K
55.89%-768K
-Change in payables and accrued expense
-89.37%411K
-47.80%1.79M
204.11%1.27M
-60.68%2.84M
-150.52%-3.24M
397.17%3.87M
96.62%3.43M
28.23%-1.22M
612.82%7.23M
900.63%6.4M
-Change in other current assets
----
----
----
--0
----
----
----
----
--0
----
-Change in other current liabilities
17.21%-255K
10.87%-246K
4.00%-240K
-27.89%-1.13M
-82.61%-294K
-25.71%-308K
-15.00%-276K
-5.93%-250K
-26.36%-882K
28.44%-161K
Cash from discontinued investing activities
Operating cash flow
-63.40%-34.03M
-41.32%-30.28M
-26.72%-33.6M
-25.17%-96.51M
-45.33%-27.75M
-7.88%-20.83M
-15.97%-21.43M
-31.06%-26.51M
-8.74%-77.1M
-0.21%-19.09M
Investing cash flow
Cash flow from continuing investing activities
-208.88%-15.93M
2,083.25%96.86M
-59,033.33%-5.32M
-14,349.51%-14.88M
-14,114.71%-4.83M
-57,200.00%-5.16M
-12,752.63%-4.88M
59.09%-9K
83.25%-103K
-161.54%-34K
Net PPE purchase and sale
-1,050.00%-92K
-1,575.00%-134K
-555.56%-59K
41.75%-60K
-2.94%-35K
11.11%-8K
78.95%-8K
59.09%-9K
83.25%-103K
-161.54%-34K
Net intangibles purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
-207.57%-15.84M
79.41%-1M
---5.26M
---14.82M
---4.8M
---5.15M
---4.88M
--0
--0
--0
Net other investing changes
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-208.88%-15.93M
2,083.25%96.86M
-59,033.33%-5.32M
-14,349.51%-14.88M
-14,114.71%-4.83M
-57,200.00%-5.16M
-12,752.63%-4.88M
59.09%-9K
83.25%-103K
-161.54%-34K
Financing cash flow
Cash flow from continuing financing activities
0
-70.93%20.16M
0
-24.49%88.52M
-99.84%97K
-59.20%21.21M
20,082.13%69.34M
-142.86%-2.12M
57.90%117.23M
146.82%60.64M
Net issuance payments of debt
--0
5,149.34%20M
--0
2,670.57%20.44M
--0
4,851.25%21.74M
217.23%381K
-84.93%-1.68M
---795K
--0
Net common stock issuance
-98.09%159K
--0
--0
-51.07%60M
-113.89%-8.62M
-84.79%8.33M
276,122.73%60.73M
-107.54%-443K
65.75%122.63M
153.44%62.01M
Proceeds from stock option exercised by employees
----
----
----
4,088.46%8.71M
----
----
----
----
-20.00%208K
3,237.86%3.44M
Net other financing activities
----
----
----
86.89%-631K
--0
---250K
----
----
---4.81M
---4.8M
Cash from discontinued financing activities
Financing cash flow
--0
-70.93%20.16M
--0
-24.49%88.52M
-99.84%97K
-59.20%21.21M
20,082.13%69.34M
-142.86%-2.12M
57.90%117.23M
146.82%60.64M
Net cash flow
Beginning cash position
7.67%148M
-35.12%61.27M
-18.52%100.25M
48.03%123.03M
63.41%132.6M
182.35%137.46M
39.40%94.43M
48.03%123.03M
2.98%83.11M
4.41%81.15M
Current changes in cash
-945.21%-49.96M
101.59%86.74M
-35.87%-38.92M
-157.16%-22.88M
-178.24%-32.48M
-114.63%-4.78M
328.16%43.03M
-87.28%-28.65M
1,368.81%40.03M
654.31%41.52M
Effect of exchange rate changes
329.17%165K
-200.00%-18K
-218.00%-59K
194.29%99K
-65.01%127K
63.45%-72K
97.03%-6K
172.46%50K
67.08%-105K
412.93%363K
End cash Position
-25.94%98.2M
7.67%148M
-35.12%61.27M
-18.52%100.25M
-18.52%100.25M
63.41%132.6M
182.35%137.46M
39.40%94.43M
48.03%123.03M
48.03%123.03M
Free cash flow
-63.77%-34.12M
-74.55%-37.41M
-26.90%-33.66M
-25.09%-96.57M
-45.25%-27.78M
-7.87%-20.84M
-15.78%-21.43M
-30.96%-26.52M
-7.95%-77.21M
-0.32%-19.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.40%-34.03M-41.32%-30.28M-26.72%-33.6M-25.17%-96.51M-45.33%-27.75M-7.88%-20.83M-15.97%-21.43M-31.06%-26.51M-8.74%-77.1M-0.21%-19.09M
Net income from continuing operations -1,492.02%-36.7M263.04%90.83M-115.51%-51.77M-7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M
Operating gains losses 107.41%1.86M-519.34%-125.22M352.90%13.76M-345.54%-7.07M---6.33M---25.16M--29.86M---5.44M687.16%2.88M----
Depreciation and amortization 156.73%267K53.97%194K-51.18%62K-18.32%419K-50.00%62K-16.13%104K-4.55%126K-4.51%127K2.81%513K-6.06%124K
Other non cash items -41.51%372K-29.04%435K-6.44%523K-6.44%2.28M11.08%471K-45.87%636K55.98%613K25.90%559K-2.01%2.44M-31.06%424K
Change In working capital -146.86%-1.66M-32.21%1.05M239.29%2.09M-94.00%344K-197.86%-5.36M2,823.08%3.54M123.73%1.55M305.33%616K482.91%5.74M512.90%5.48M
-Change in inventory ---1.61M------------------0----------------
-Change in prepaid assets -905.00%-201K120.93%336K-49.04%1.06M-124.59%-1.37M-138.15%-1.83M96.98%-20K-97.66%-1.61M27.62%2.08M65.24%-610K55.89%-768K
-Change in payables and accrued expense -89.37%411K-47.80%1.79M204.11%1.27M-60.68%2.84M-150.52%-3.24M397.17%3.87M96.62%3.43M28.23%-1.22M612.82%7.23M900.63%6.4M
-Change in other current assets --------------0------------------0----
-Change in other current liabilities 17.21%-255K10.87%-246K4.00%-240K-27.89%-1.13M-82.61%-294K-25.71%-308K-15.00%-276K-5.93%-250K-26.36%-882K28.44%-161K
Cash from discontinued investing activities
Operating cash flow -63.40%-34.03M-41.32%-30.28M-26.72%-33.6M-25.17%-96.51M-45.33%-27.75M-7.88%-20.83M-15.97%-21.43M-31.06%-26.51M-8.74%-77.1M-0.21%-19.09M
Investing cash flow
Cash flow from continuing investing activities -208.88%-15.93M2,083.25%96.86M-59,033.33%-5.32M-14,349.51%-14.88M-14,114.71%-4.83M-57,200.00%-5.16M-12,752.63%-4.88M59.09%-9K83.25%-103K-161.54%-34K
Net PPE purchase and sale -1,050.00%-92K-1,575.00%-134K-555.56%-59K41.75%-60K-2.94%-35K11.11%-8K78.95%-8K59.09%-9K83.25%-103K-161.54%-34K
Net intangibles purchase and sale --0------------------0----------------
Net investment purchase and sale -207.57%-15.84M79.41%-1M---5.26M---14.82M---4.8M---5.15M---4.88M--0--0--0
Net other investing changes --0------------------------------------
Cash from discontinued investing activities
Investing cash flow -208.88%-15.93M2,083.25%96.86M-59,033.33%-5.32M-14,349.51%-14.88M-14,114.71%-4.83M-57,200.00%-5.16M-12,752.63%-4.88M59.09%-9K83.25%-103K-161.54%-34K
Financing cash flow
Cash flow from continuing financing activities 0-70.93%20.16M0-24.49%88.52M-99.84%97K-59.20%21.21M20,082.13%69.34M-142.86%-2.12M57.90%117.23M146.82%60.64M
Net issuance payments of debt --05,149.34%20M--02,670.57%20.44M--04,851.25%21.74M217.23%381K-84.93%-1.68M---795K--0
Net common stock issuance -98.09%159K--0--0-51.07%60M-113.89%-8.62M-84.79%8.33M276,122.73%60.73M-107.54%-443K65.75%122.63M153.44%62.01M
Proceeds from stock option exercised by employees ------------4,088.46%8.71M-----------------20.00%208K3,237.86%3.44M
Net other financing activities ------------86.89%-631K--0---250K-----------4.81M---4.8M
Cash from discontinued financing activities
Financing cash flow --0-70.93%20.16M--0-24.49%88.52M-99.84%97K-59.20%21.21M20,082.13%69.34M-142.86%-2.12M57.90%117.23M146.82%60.64M
Net cash flow
Beginning cash position 7.67%148M-35.12%61.27M-18.52%100.25M48.03%123.03M63.41%132.6M182.35%137.46M39.40%94.43M48.03%123.03M2.98%83.11M4.41%81.15M
Current changes in cash -945.21%-49.96M101.59%86.74M-35.87%-38.92M-157.16%-22.88M-178.24%-32.48M-114.63%-4.78M328.16%43.03M-87.28%-28.65M1,368.81%40.03M654.31%41.52M
Effect of exchange rate changes 329.17%165K-200.00%-18K-218.00%-59K194.29%99K-65.01%127K63.45%-72K97.03%-6K172.46%50K67.08%-105K412.93%363K
End cash Position -25.94%98.2M7.67%148M-35.12%61.27M-18.52%100.25M-18.52%100.25M63.41%132.6M182.35%137.46M39.40%94.43M48.03%123.03M48.03%123.03M
Free cash flow -63.77%-34.12M-74.55%-37.41M-26.90%-33.66M-25.09%-96.57M-45.25%-27.78M-7.87%-20.84M-15.78%-21.43M-30.96%-26.52M-7.95%-77.21M-0.32%-19.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data